This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Palau Pharma, S.A.
Drug Names(s): UR-67767
Description: UR-67767 is a balanced inhibitor of the four Jak isoenzymes. Jak1, Jak2, Jak3 and Tyk2 are tyrosine kinases associated with various cytokine receptors and translate signals triggered upon cytokine binding into intracellular responses, contributing to the genesis and amplification of inflammatory, autoimmune and oncology diseases.
Additional information available to subscribers only: